Header cover image

Egyptian (OMX) Pharma Industry Analysis

UpdatedMay 19, 2024
DataAggregated Company Financials
Companies11
  • 7D1.2%
  • 3M-21.7%
  • 1Y21.8%
  • YTD-2.3%

Over the last 7 days, the Pharma industry has risen 1.2%, driven by gains from Egyptian International Pharmaceutical Industries of 3.3%. This means that the industry has gained 22% over the past year. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 20 May 2024ج.م18.0bج.م20.1bج.م1.8b7.8x9.9x0.9x
Wed, 17 Apr 2024ج.م21.1bج.م19.3bج.م1.8b8.4x11.9x1.1x
Fri, 15 Mar 2024ج.م22.5bج.م18.9bج.م2.2b9.5x10.1x1.2x
Sun, 11 Feb 2024ج.م21.5bج.م18.5bج.م2.4b8.8x9x1.2x
Tue, 09 Jan 2024ج.م18.6bج.م16.0bج.م2.2b7.1x8.6x1.2x
Thu, 07 Dec 2023ج.م19.7bج.م16.5bج.م2.2b9.3x9.1x1.2x
Sat, 04 Nov 2023ج.م15.2bج.م15.4bج.م1.9b6.5x7.8x1x
Mon, 02 Oct 2023ج.م14.0bج.م15.3bج.م1.9b5.6x7.3x0.9x
Wed, 30 Aug 2023ج.م13.9bج.م15.8bج.م2.1b7.2x6.6x0.9x
Fri, 28 Jul 2023ج.م13.5bج.م15.6bج.م2.1b6.9x6.4x0.9x
Sun, 25 Jun 2023ج.م13.8bج.م16.2bج.م2.2b5.4x6.2x0.9x
Tue, 23 May 2023ج.م13.7bج.م16.2bج.م2.4b4.3x5.7x0.8x
Thu, 20 Apr 2023ج.م14.6bج.م16.2bج.م2.4b5.2x6.1x0.9x
Sat, 18 Mar 2023ج.م13.4bج.م15.7bج.م2.3b5.3x5.8x0.9x
Mon, 13 Feb 2023ج.م14.9bج.م15.6bج.م2.3b5.4x6.5x1x
Wed, 11 Jan 2023ج.م14.9bج.م15.6bج.م2.3b5.4x6.6x1x
Fri, 09 Dec 2022ج.م15.1bج.م15.6bج.م2.3b4.9x6.6x1x
Sun, 06 Nov 2022ج.م12.9bج.م15.1bج.م2.2b5.1x6x0.9x
Tue, 04 Oct 2022ج.م12.6bج.م15.1bج.م2.2b4.7x5.8x0.8x
Thu, 01 Sep 2022ج.م13.0bج.م14.3bج.م2.0b6.1x6.4x0.9x
Sat, 30 Jul 2022ج.م12.4bج.م14.1bج.م1.9b5.6x6.4x0.9x
Mon, 27 Jun 2022ج.م12.0bج.م14.1bج.م1.9b5.7x6.3x0.9x
Wed, 25 May 2022ج.م12.0bج.م11.9bج.م1.7b5.6x7.2x1x
Fri, 22 Apr 2022ج.م12.3bج.م11.8bج.م1.7b5.5x7.5x1x
Sun, 20 Mar 2022ج.م12.6bج.م13.7bج.م1.8b6.5x6.8x0.9x
Tue, 15 Feb 2022ج.م13.0bج.م13.3bج.م1.8b6.6x7.1x1x
Thu, 13 Jan 2022ج.م13.9bج.م13.3bج.م1.8b6.4x7.6x1x
Sat, 11 Dec 2021ج.م12.5bج.م13.2bج.م1.8b5.9x7x0.9x
Mon, 08 Nov 2021ج.م12.1bج.م12.9bج.م1.8b19.6x6.8x0.9x
Wed, 06 Oct 2021ج.م12.9bج.م12.9bج.م1.8b5.5x7.3x1x
Fri, 03 Sep 2021ج.م14.0bج.م13.0bج.م1.8b5.6x7.8x1.1x
Sun, 01 Aug 2021ج.م13.7bج.م13.0bج.م1.8b5.4x7.6x1.1x
Price to Earnings Ratio

7.4x


Total Market Cap: ج.م12.3bTotal Earnings: ج.م1.7bTotal Revenue: ج.م12.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 7.2x202220232024
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 9.9x which is higher than its 3-year average PE of 7.2x.
  • The industry is trading close to its 3-year average PS ratio of 0.97x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 3.1% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare industry?

EG Market2.81%
Healthcare1.63%
Pharma1.22%
Pharma1.22%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)Eج.م2.1910.6%
+ج.م313.0m
40.1%PE15.3x
PHAR Egyptian International Pharmaceutical Industriesج.م35.835.4%
+ج.م273.7m
38.1%PE6.5x
BIOC GlaxoSmithKlineEج.م29.000.8%
+ج.م18.4m
-10.9%PE64.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.